Remaining useful life estimation software helps determine the operational life left in an asset before it needs maintenance or replacement. It plays a crucial role in predictive maintenance by calculating the remaining useful operating hours or cycles of critical assets such as motors, engines, turbines, and other mechanical and structural assets. The software utilizes mathematical models and algorithms that analyze various condition monitoring data such as temperature, vibration, corrosion, operational loads to predict asset deterioration. This allows planning maintenance activities well in advance to avoid unexpected downtime. The growing need for reducing maintenance costs and increasing equipment uptime is driving many industries to adopt remaining useful life estimation solutions.
The Global Remaining Useful Life Estimation Software Market Size is estimated to be valued at US$ 403.2 Bn in 2024 and is expected to exhibit a CAGR of 23% over the forecast period 2024 to 2030.
Key Takeaways
Key players operating in the Remaining Useful Life Estimation Software market are VanadiumCorp Resource Inc., Bushveld Minerals Limited, HighVeld Steel and Vanadium Corporation Ltd., Largo Resources Ltd., American Vanadium Corp., Sumitomo Electric Industries Ltd., Prudent Energy Inc., Vanchem Vanadium Products (Pty) Ltd., Pu Neng Energy, CellCube Energy Storage Systems Inc.
The growing demand from industries such as oil & gas, energy, transportation is fueling the growth of remaining useful life estimation software market. The software helps manage maintenance costs of assets across their lifecycle. Additionally, aging infrastructure in developed regions is further driving the need to implement predictive maintenance strategies using such solutions.
Technological advancements in IoT, AI and machine learning have enabled remaining useful life estimation software to analyze huge volumes of condition monitoring data from multiple assets to deliver more accurate predictions. Advanced algorithms based on deep learning techniques are helping derive meaningful insights from data to determine assets' residual life more precisely. This is improving maintenance planning and operational efficiency.
Market Trends
One of the key trends is the integration of remaining useful life estimation solutions with IoT and AI. As more assets become connected and generate huge streams of real-time data, the software is leveraging technologies like machine learning, deep learning, and big data analytics to deliver more accurate predictions.
Adoption of cloud-based RUL software is also gaining traction as it enables condition-based monitoring of globalized assets. The cloud model improves collaboration, allows access from remote locations, and reduces IT costs. Many vendors are offering SaaS-based remaining useful life estimation systems to make them more scalable.
Market Opportunities
Growing infrastructure development across developing regions presents significant opportunities. As these nations look to modernize their facilities, the need for asset management will rise significantly.
Implementation of Industry 4.0 technologies also creates prospects with increasing use of predictive maintenance in manufacturing. Integration of remaining useful life software with smart factories, predictive diagnostics, and maintenance platforms will be a key focus area.
Collaboration with IIoT technology providers also offers scope with growing interconnectivity of industrial equipment. Combining machine data with remaining life calculations can deliver advanced monitoring solutions.
Impact of COVID-19 on Remaining Useful Life Estimation Software Market Growth
The COVID-19 pandemic has significantly impacted the growth of the remaining useful life estimation software market. Due to lockdowns and supply chain disruptions across the globe during the COVID-19 outbreak, industries faced challenges in effectively assessing and predicting the remaining useful life of their assets. This led to reduced spending on maintenance, inspection, repair and asset management solutions by companies during 2020-2021. The demand for remaining useful life estimation solutions also declined as industries focused more on core operations during the crisis period.
However, with industries now gradually recovering and resuming operations post pandemic, the focus on asset management and predictive maintenance is increasing steadily again. Companies are recognizing the need to digitally transform their maintenance processes and infrastructure to make them more resilient against future disruptions. The deployment of remaining useful life estimation software is helping industries optimize maintenance costs, enhance asset utilization andplanningthrough remote condition monitoring capabilities. Industries are investing more in digital twin and AI-powered predictive maintenance technologies to improve asset performance, reliability and safety in the long run. The future outlook for remaining useful life estimation market is positive with industries increasingly embracing industry 4.0 solutions for ensuring business continuity.
In terms of geographical regions, North America dominates the remaining useful life estimation software market in terms of value. It accounted for over 35% share of the global market revenue in 2024 owing to high adoption of asset management and predictive maintenancesolutions across manufacturing, oil & gas, aerospace & defense and other process industries in US and Canada. Asia Pacific is the fastest growing regional market for remaining useful life estimation software driven by rapid industrialization and increasing investments in smart factory deployments by China, India, Japan and Southeast Asian countries.
Get More Insights on Remaining Useful Life Estimation Software Market
The ‘Global Product Life Cycle Management (PLM) Software Market Report’ is a comprehensive and in-depth stuxxdy on the size, share, growth, trends, demand and estimation with a focus on the latest development.
The report provides key statistics on the market status with highlights on various important strategic such as mergers, acquisitions, partnership and other development.This section of the product life cycle management (plm) software market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.Request a FREE Sample Copy of Global Product Life Cycle Management (PLM) Software Market Report with Full TOC At: https://www.valuemarketresearch.com/contact/product-life-cycle-management-plm-software-market/download-sampleBy ComponentSoftwareServiceBy Deployment ModeOn-premiseOn-cloudBy End-UserAutomotive and TransportationIndustrial MachineryElectronics and SemiconductorsRetailAerospace and DefenseEnergy and UtilitiesPharmaceuticalsIt & TelecomOthersBrowse Full Global Product Life Cycle Management (PLM) Software Market Research Report With TOC At: https://www.valuemarketresearch.com/report/product-life-cycle-management-plm-software-marketThe research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the product life cycle management (plm) software market include SAP SE, IBM Corporation, Dassault Systemes, Atos SE, Autodesk Inc., PTC Inc., Siemens AG, Accenture PLC, Hewlett-Packard Company, Oracle Corporation, Aras Corporation, among others.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.This section covers the regional outlook, which accentuates current and future demand for the Product Life Cycle Management (PLM) Software market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.Purchase complete Global Product Life Cycle Management (PLM) Software Market Research Report At: https://www.valuemarketresearch.com/contact/product-life-cycle-management-plm-software-market/buy-nowAbout Us:Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information.We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.Contact:Value Market Research401/402, TFM, Nagras Road, Aundh, Pune-7.Maharashtra, INDIA.Tel: +1-888-294-1147Email: [email protected]: https://www.valuemarketresearch.com
Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight (Albany, US) DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030" to its portfolio.Key Highlights from report are:As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017.
These cases are expected to grow with a significant CAGR in the study period 2017–2030.There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting.The market size of NSCLC in the 7MM is expected to increase during study period.
According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.Request for free sample pages to know more on Non-Small Cell Lung Cancer Market Forecast NSCLC is the most common type of lung cancer accounted for approximately 85% of all lung cancers.
The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.The total NSCLC incident cases in the 7MM were observed to be 484,726 cases in 2017.Click here to know more on Non-Small Cell Lung Cancer pipelineNSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.
The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many others Key Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.
Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.
